Download PDF
Thromb Haemost 2018; 118(04): 676-687
DOI: 10.1055/s-0038-1636528
Coagulation and Fibrinolysis
Schattauer GmbH Stuttgart

Low Plasma ADAMTS13 Activity Is Associated with Coagulopathy, Endothelial Cell Damage and Mortality after Severe Paediatric Trauma

Robert T. Russell
1   Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama
,
Jenny K. McDaniel
2   Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama
,
Wenjing Cao
2   Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama
,
Michelle Shroyer
1   Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama
,
Brant M. Wagener
3   Department of Anesthesiology and Perioperative Medicine, The University of Alabama at Birmingham, Birmingham, Alabama
,
X. Long Zheng
2   Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama
,
Jean-François Pittet
3   Department of Anesthesiology and Perioperative Medicine, The University of Alabama at Birmingham, Birmingham, Alabama
› Author Affiliations
Further Information

Publication History

22 October 2017

15 January 2018

Publication Date:
04 April 2018 (online)

    Permissions and Reprints

Abstract

Decrease of plasma activity of ADAMTS13, a metalloenzyme that cleaves von Willebrand factor (VWF) and prevents adhesion and aggregation of platelets, has been reported early after onset of systemic inflammation resulting from infections and after severe trauma. Here, we determined whether trauma-induced systemic (sterile) inflammation would be associated with a reduction of plasma ADAMTS13 activity in paediatric patients and its association with disease severity and outcome. Paediatric patients (n = 106) with severe trauma at a level 1 paediatric trauma centre between 2014 and 2016 were prospectively enrolled. Blood samples were collected upon arrival and at 24 hours and analysed for plasma levels of ADAMTS13 activity, VWF antigen, collagen binding activity, human neutrophil peptides (HNP) 1–3, coagulation abnormalities, endothelial glycocalyx damage and clinical outcome. Plasma samples were also collected for similar measurements from 52 healthy paediatric controls who underwent elective minor surgery. The median age of patients was 9 years with 81% sustaining blunt trauma. The median injury severity score was 22 and the mortality rate was 11%. Plasma levels of ADAMTS13 activity were significantly lower and plasma levels of VWF antigen and HNP 1–3 proteins were significantly higher for paediatric trauma patients on admission and at 24 hours when compared with controls. Finally, the lowest plasma ADAMTS13 activity was found in patients who died from their injuries. We conclude that relative plasma deficiency of ADAMTS13 activity may be associated with more severe traumatic injury, significant endothelial glycocalyx damage, coagulation abnormalities and mortality after severe trauma in paediatric patients.

Keywords

paediatric - trauma - injury - coagulopathy - ADAMTS13 - von Willebrand Factor - human neutrophil peptide

Authors' Contribution

R.T.R., X.L.Z. and J-F.P. contributed to study design and wrote the manuscript. R.T.R., J-F.P., J.K.M., W.C. and X.L.Z. contributed to experiments, data collection and data interpretation. M.S. performed statistical analysis. All other authors contributed to revising and finalizing the manuscript.


 

  • References

  • 1 Committee on Child Abuse and Neglect; Committee on Injury, Violence, and Poison Prevention; Council on Community Pediatrics. American Academy of Pediatrics. Policy statement--child fatality review. Pediatrics 2010; 126 (03) 592-596
    CrossrefPubMedGoogle Scholar
  • 2 Albers JM, Pavenstaedt H, Dlugos C. , et al. An increased pulsatility index in transcranial Doppler sonography is associated with Shiga-toxin-related encephalopathy in hemolytic uremic syndrome. Cerebrovasc Dis 2012; 33 (04) 403-404
    CrossrefPubMedGoogle Scholar
  • 3 Lao Z, Gifford M, Dalal K. Economic cost of childhood unintentional injuries. Int J Prev Med 2012; 3 (05) 303-312
    PubMedGoogle Scholar
  • 4 Nystrup KB, Stensballe J, Bøttger M, Johansson PI, Ostrowski SR. Transfusion therapy in paediatric trauma patients: a review of the literature. Scand J Trauma Resusc Emerg Med 2015; 23: 21
    CrossrefPubMedGoogle Scholar
  • 5 Christiaans SC, Duhachek-Stapelman AL, Russell RT, Lisco SJ, Kerby JD, Pittet JF. Coagulopathy after severe pediatric trauma. Shock 2014; 41 (06) 476-490
    CrossrefPubMedGoogle Scholar
  • 6 Whittaker B, Christiaans SC, Altice JL. , et al. Early coagulopathy is an independent predictor of mortality in children after severe trauma. Shock 2013; 39 (05) 421-426
    CrossrefPubMedGoogle Scholar
  • 7 Hendrickson JE, Shaz BH, Pereira G. , et al. Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr 2012; 160 (02) 204-209.e3
    CrossrefPubMedGoogle Scholar
  • 8 Liras IN, Caplan HW, Stensballe J, Wade CE, Cox CS, Cotton BA. Prevalence and impact of admission acute traumatic coagulopathy on treatment intensity, resource use, and mortality: an evaluation of 956 severely injured children and adolescents. J Am Coll Surg 2017; 224 (04) 625-632
    CrossrefPubMedGoogle Scholar
  • 9 Leeper CM, Kutcher M, Nasr I. , et al. Acute traumatic coagulopathy in a critically injured pediatric population: definition, trend over time, and outcomes. J Trauma Acute Care Surg 2016; 81 (01) 34-41
    CrossrefPubMedGoogle Scholar
  • 10 Suominen P, Kivioja A, Ohman J, Korpela R, Rintala R, Olkkola KT. Severe and fatal childhood trauma. Injury 1998; 29 (06) 425-430
    CrossrefPubMedGoogle Scholar
  • 11 Calkins CM, Bensard DD, Moore EE. , et al. The injured child is resistant to multiple organ failure: a different inflammatory response?. J Trauma 2002; 53 (06) 1058-1063
    CrossrefPubMedGoogle Scholar
  • 12 Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254 (02) 194-200
    CrossrefPubMedGoogle Scholar
  • 13 Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 2012; 73 (01) 60-66
    CrossrefPubMedGoogle Scholar
  • 14 Johansson PI, Windeløv NA, Rasmussen LS, Sørensen AM, Ostrowski SR. Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock 2013; 6 (03) 171-175
    CrossrefPubMedGoogle Scholar
  • 15 Kremer Hovinga JA, Zeerleder S, Kessler P. , et al. ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 2007; 5 (11) 2284-2290
    CrossrefPubMedGoogle Scholar
  • 16 Hack CE, Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 2001; 29 (7, Suppl): S21-S27
    CrossrefPubMedGoogle Scholar
  • 17 Martin K, Borgel D, Lerolle N. , et al. Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 2007; 35 (10) 2375-2382
    CrossrefPubMedGoogle Scholar
  • 18 Rahbar E, Cardenas JC, Baimukanova G. , et al. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med 2015; 13: 117
    CrossrefPubMedGoogle Scholar
  • 19 Kozar RA, Pati S. Syndecan-1 restitution by plasma after hemorrhagic shock. J Trauma Acute Care Surg 2015; 78 (06) (Suppl. 01) S83-S86
    CrossrefPubMedGoogle Scholar
  • 20 Gonzalez Rodriguez E, Ostrowski SR, Cardenas JC. , et al. Syndecan-1: a quantitative marker for the endotheliopathy of trauma. J Am Coll Surg 2017; 225 (03) 419-427
    CrossrefPubMedGoogle Scholar
  • 21 Ganz T. Defensins and host defense. Science 1999; 286 (5439): 420-421
    CrossrefPubMedGoogle Scholar
  • 22 Ganz T, Selsted ME, Szklarek D. , et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76 (04) 1427-1435
    CrossrefPubMedGoogle Scholar
  • 23 Lehrer RI, Lu W. α-Defensins in human innate immunity. Immunol Rev 2012; 245 (01) 84-112
    CrossrefPubMedGoogle Scholar
  • 24 Horn M, Bertling A, Brodde MF. , et al. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa. J Thromb Haemost 2012; 10 (04) 647-661
    CrossrefPubMedGoogle Scholar
  • 25 Pillai VG, Bao J, Zander CB. , et al. Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP. Blood 2016; 128 (01) 110-119
    CrossrefPubMedGoogle Scholar
  • 26 Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129 (01) 93-100
    CrossrefPubMedGoogle Scholar
  • 27 Raife TJ, Cao W, Atkinson BS. , et al. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. Blood 2009; 114 (08) 1666-1674
    CrossrefPubMedGoogle Scholar
  • 28 Cao W, Pham HP, Williams LA. , et al. Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura. Haematologica 2016; 101 (11) 1319-1326
    CrossrefPubMedGoogle Scholar
  • 29 Mimuro J, Niimura M, Kashiwakura Y. , et al. Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia. Thromb Res 2008; 122 (01) 91-97
    CrossrefPubMedGoogle Scholar
  • 30 Mannucci PM, Capoferri C, Canciani MT. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 2004; 126 (02) 213-218
    CrossrefPubMedGoogle Scholar
  • 31 Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultra large von Willebrand factor multimers under flow. Blood 2004; 104 (01) 100-106
    CrossrefPubMedGoogle Scholar
  • 32 Cao WJ, Niiya M, Zheng XW, Shang DZ, Zheng XL. Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells. J Thromb Haemost 2008; 6 (07) 1233-1235
    CrossrefPubMedGoogle Scholar
  • 33 Meiring M, Allers W, Le Roux E. Tissue factor: a potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells. Int J Med Sci 2016; 13 (10) 759-764
    CrossrefPubMedGoogle Scholar
  • 34 Bandyopadhyay G, Bandyopadhyay S, Bankey PE, Miller-Graziano CL. Elevated postinjury thrombospondin 1-CD47 triggering aids differentiation of patients' defective inflammatory CD1a+dendritic cells. J Leukoc Biol 2014; 96 (05) 797-807
    CrossrefPubMedGoogle Scholar
  • 35 Xie L, Chesterman CN, Hogg PJ. Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med 2001; 193 (12) 1341-1349
    CrossrefPubMedGoogle Scholar
  • 36 Bonnefoy A, Daenens K, Feys HB. , et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 2006; 107 (03) 955-964
    CrossrefPubMedGoogle Scholar
  • 37 Tang N, Yin S, Sun Z, Pan Y. Time course of soluble P-selectin and von Willebrand factor levels in trauma patients: a prospective observational study. Scand J Trauma Resusc Emerg Med 2013; 21: 70
    CrossrefPubMedGoogle Scholar
  • 38 Kumar M, Cao W, McDaniel JK. , et al. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage. Thromb Haemost 2017; 117 (04) 691-699
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 De Oliveira CO, Reimer AG, Da Rocha AB. , et al. Plasma von Willebrand factor levels correlate with clinical outcome of severe traumatic brain injury. J Neurotrauma 2007; 24 (08) 1331-1338
    CrossrefPubMedGoogle Scholar
  • 40 Johansson PI, Henriksen HH, Stensballe J. , et al. Traumatic endotheliopathy: a prospective observational study of 424 severely injured patients. Ann Surg 2017; 265 (03) 597-603
    CrossrefPubMedGoogle Scholar
  • 41 Russell RT, Christiaans SC, Nice TR. , et al. Histone-complexed DNA fragments levels are associated with coagulopathy, endothelial cell damage, and increased mortality after severe pediatric trauma. Shock 2018; 49 (01) 44-52
    CrossrefPubMedGoogle Scholar
  • 42 Schwameis M, Schörgenhofer C, Assinger A, Steiner MM, Jilma B. VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP. Thromb Haemost 2015; 113 (04) 708-718
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Ganter MT, Brohi K, Cohen MJ. , et al. Role of the alternative pathway in the early complement activation following major trauma. Shock 2007; 28 (01) 29-34
    CrossrefPubMedGoogle Scholar
  • 44 Hyun J, Kim HK, Kim JE. , et al. Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation. Thromb Res 2009; 124 (01) 75-79
    CrossrefPubMedGoogle Scholar
  • 45 Chinen Y, Kuroda J, Ohshiro M. , et al. Low ADAMTS-13 activity during hemorrhagic events with disseminated intravascular coagulation. Int J Hematol 2013; 97 (04) 511-519
    CrossrefPubMedGoogle Scholar
  • 46 Soares RP, Bydlowski SP, Jatene MB, Hironaka JF, Lopes AA. Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease. Clinics (Sao Paulo) 2013; 68 (04) 531-536
    CrossrefPubMedGoogle Scholar
  • 47 Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet JF. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma 2007; 63 (06) 1254-1261 , discussion 1261–1262
    CrossrefPubMedGoogle Scholar
  • 48 Christiaans SC, Wagener BM, Esmon CT, Pittet JF. Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol 2013; 305 (07) L455-L466
    CrossrefPubMedGoogle Scholar
  • 49 Liu L, Choi H, Bernardo A. , et al. Platelet-derived VWF-cleaving metalloprotease ADAMTS-13. J Thromb Haemost 2005; 3 (11) 2536-2544
    CrossrefPubMedGoogle Scholar
  • 50 Shang D, Zheng XW, Niiya M, Zheng XL. Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. Blood 2006; 108 (07) 2207-2215
    CrossrefPubMedGoogle Scholar